BioTechGrid

Germany-based Axplora says it has invested €50 million ($51.8 million) in its Mourenx site in Southwest France. Axplora specializes in…

eXoZymes CEO Michael Heltzen Publicly traded Invizyne Technologies is renaming itself eXoZymes, a rebranding intended to raise the company’s profile…

In-line buffer management markedly reduced the production bottlenecks and manufacturing costs inherent in biopharmaceutical manufacturing. Additional cost reductions are possible,…

In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The…

A bioprocessing research and training institute in Ireland has successfully tested two new techniques for noninvasive monitoring of cell viability.…

Bioprocessors can make therapeutic proteins with a variety of techniques, from batch and fed-batch processing to perfusion and hybrid systems.…

NanoMosaic published a scientific white paper detailing a study conducted with Bristol Myers Squibb (BMS) that explores the potential of…